	Erythropoiesis-stimulating agents
Iron supplementation
Infection
Iron status
Inflammation
	adult hemodialysis patients
intravenous iron
serum iron concentration
ferric gluconate
iron
iron status
ESA therapy
hemoglobin levels
parenteral iron preparations
anemia
oxidative stress
iron storage
end-stage renal disease
therapy
patients
dose
levels
kidney function
adverse events
ascorbic acid
effective
increase
study
children
usual adult dose
reactions
erythropoietic response
hemodialysis
chronic kidney disease
adult
oral
international recommendations
relevant clinical studies
chronic inflammation
acute
complications
TSAT
vitro studies
ESA
ferritin
guidelines
higher
intravenous injection
absolute
hemoglobin
low
ESRD
months

